News Lundbeck names AI head in quest to become 'bionic' company Lundbeck has appointed Markus Kede to the newly created role of chief AI officer, charged with driving its ambition to become a 'bionic' company.
Digital Accelerating the medical wheel with AI: From engagement to i... Explore an AI-powered 360 Medical Engagement vision that links engagement, insight, evidence, and strategy in a continuous loop.
Digital AI's promise, biotech's peril: How unequal access to computi... Many biotechs remain locked out of the AI revolution by a combination of cost, complexity, and lack of access to state-of-the-art infrastructure.
Digital Sponsored Clinical trials at the core: Decentralised, AI targeted, ESG... For Inventus' Steve Sanghera and Jim Michel 2025 was a year of progress in clinical trial enablement.
Digital Healthcare Predictions for the UK in 2026 Digital systems are steadily replacing legacy software and automation tools roll out at speed to cut back the time clinicians spend on manual tasks.
Digital An AI supercomputer and discovering next-gen brain disorder ... Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.
Oncology Hernexeos and what’s next, with Vicky Brown At Reuters Pharma USA this week, Boehringer Ingelheim's Vicky Brown spoke with us about the company's recent approval for Hernexeos in NSCLC.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.